EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.
about
Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and ImagingPromising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeuticsPersonalized treatment for advanced colorectal cancer: KRAS and beyondCancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Multifunctional nanoparticles for brain tumor imaging and therapy.Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapyNovel delivery strategies for glioblastomaEGF receptor-targeted nanocarriers for enhanced cancer treatmentAdjuvant chemotherapy for brain tumors delivered via a novel intra-cavity moldable polymer matrixNanoparticles for imaging and treating brain cancerMagnetic Nanoparticle Facilitated Drug Delivery for Cancer Therapy with Targeted and Image-Guided ApproachesRecent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applicationsBionanotechnology and the future of glioma.Nanoparticles for Improving Cancer Diagnosis.Radiation-induced tumor neoantigens: imaging and therapeutic implications.Magnetofection: a reproducible method for gene delivery to melanoma cells.Block copolymer cross-linked nanoassemblies improve particle stability and biocompatibility of superparamagnetic iron oxide nanoparticlesThe art of attraction: applications of multifunctional magnetic nanomaterials for malignant glioma.Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.Benefits of dynamic susceptibility-weighted contrast-enhanced perfusion MRI for glioma diagnosis and therapy.Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors.Facile synthesis of RGD peptide-modified iron oxide nanoparticles with ultrahigh relaxivity for targeted MR imaging of tumors.Application of iron oxide nanoparticles in glioma imaging and therapy: from bench to bedside.Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect.Nanoparticle-Based Magnetic Resonance Imaging on Tumor-Associated Macrophages and Inflammation.Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.Ultrashort echo time (UTE) imaging of receptor targeted magnetic iron oxide nanoparticles in mouse tumor modelsMinimizing the non-specific binding of nanoparticles to the brain enables active targeting of Fn14-positive glioblastoma cells.Cerebral blood volume calculated by dynamic susceptibility contrast-enhanced perfusion MR imaging: preliminary correlation study with glioblastoma genetic profiles.Imaging the delivery of brain-penetrating PLGA nanoparticles in the brain using magnetic resonance.Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticlesCancer cell invasion: treatment and monitoring opportunities in nanomedicine.Molecular imaging in endoscopy.Oh the irony: Iron as a cancer cause or cure?Innovative Therapies against Human Glioblastoma MultiformeMolecular imaging with theranostic nanoparticles.Cancer theranostics: the rise of targeted magnetic nanoparticles.Tumor cell targeting by iron oxide nanoparticles is dominated by different factors in vitro versus in vivo.Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors.
P2860
Q26778234-A7653DCA-F62E-4F6C-8018-CB9B7F74724FQ26778701-B376EC33-1BA6-4341-AE34-7D60E7E85EFFQ26795601-9BEDDA1F-C3D8-42AF-922E-4C89B1FA641FQ26822817-4A5D3D6B-C6DD-4400-BC8B-CC3BC2516F4EQ26830028-AEC27A1F-0A54-4444-8E68-6730B669BE4EQ26865418-626B943B-7BBF-462F-8CBD-354CE56B55C7Q27004205-4D89D164-D2F9-4FA3-8012-81934F9246DEQ27006099-19328211-91E0-436C-AB62-68D2123F8E96Q27013001-C8AF99AD-402B-49AF-AB76-1AC4C5AE45D1Q27303877-2DE76B36-4F59-4C07-AEF8-F6B6F8E1E47EQ28394053-D295A922-9058-45D4-A3D9-B6D2EF8242ECQ30354223-4BFF1F32-249F-47DC-B378-D3D257357BADQ30369384-AFB1C81A-19FA-4926-972C-56A6A54EF914Q30417964-C7B9F176-C77F-4CD8-AF90-75C4DF7FBF92Q30442412-4DB1DDF2-0874-4F3B-865F-CBC8B9095587Q30473856-C64C4EF2-41E1-47A8-B3A8-2BF01F6EF06BQ30559364-7F709B1E-9B7F-4A6E-922A-FC714CB0A7F3Q30574016-A7095691-E57E-4700-8E77-D6A2359768B2Q30809060-66903D35-9F2E-48F6-A33B-3B0ED7AB70BBQ30827270-00C5DCDF-4E14-43A9-88F2-C19B57F3FD24Q30872679-384F61AA-967E-4485-88AD-EF4324375532Q30930526-F2F8EF09-93B7-49BB-BCF9-DC41299CEBBEQ30983807-CF7D7D64-4D4F-4E5F-8973-7FE2C71DE816Q31065446-52E86188-06B2-4DDF-B933-532ABF0C1EF8Q33689872-5DE523E7-ECF6-42EB-ADF6-C56E9309A459Q33710955-ABFE30C3-DC7B-4B50-86FB-E44289406C9AQ34104503-330E6791-091C-4828-845D-539413BE4306Q34662745-14496269-1AAD-42BD-BA4E-C378A8554B56Q34785621-C3033EC9-5D39-41BB-AC04-7CDEC5E44725Q34971940-63EE1BAA-B7BF-49B8-B265-234C59AB4136Q35070535-2402B51F-A465-47ED-8E60-10DEEE7329CDQ35087646-711BDF53-6FF9-4F0B-AFCB-13DAA2C6CB91Q35093966-3B65ACF7-C8D8-431B-82CD-26D849C6F217Q35185271-6F4EA3F8-431A-495D-9B45-B54EEADA1EE2Q35343242-39C0254D-15C8-46CA-A101-079BEB23BEF6Q35374492-56D19BF9-3C28-468B-82BB-8E006FC4DFF8Q35388723-2155A91A-25C0-41BC-B039-49D17CCA2C51Q35533813-2EC4FBE7-048E-40E5-9AF8-350DC7620B4DQ35563975-20A1DD31-C4B2-4891-A297-BB45BC8BE61DQ35624123-5C3E72EF-3467-4267-8B47-C37D466130C6
P2860
EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
EGFRvIII antibody-conjugated i ...... geted therapy of glioblastoma.
@en
EGFRvIII antibody-conjugated i ...... geted therapy of glioblastoma.
@nl
type
label
EGFRvIII antibody-conjugated i ...... geted therapy of glioblastoma.
@en
EGFRvIII antibody-conjugated i ...... geted therapy of glioblastoma.
@nl
prefLabel
EGFRvIII antibody-conjugated i ...... geted therapy of glioblastoma.
@en
EGFRvIII antibody-conjugated i ...... geted therapy of glioblastoma.
@nl
P2093
P2860
P921
P1433
P1476
EGFRvIII antibody-conjugated i ...... geted therapy of glioblastoma.
@en
P2093
Albert J Schuette
Costas G Hadjipanayis
Hongwei Chen
Milota Kaluzova
Revaz Machaidze
Xinying Wu
P2860
P304
P356
10.1158/0008-5472.CAN-10-1022
P407
P577
2010-07-20T00:00:00Z